SCOPUS 정보 검색 플랫폼

Volumn 105, Issue 5, 2002, Pages 371-378

Prophylaxis of venous thromboembolism with subcutaneous melagatran in total hip or total knee replacement: Results from Phase II studies

(11) Eriksson, Bengt I a Ögren, Mats b Eriksson, Ulf G b Kälebo, Peter a Ahnfelt, Lennart c Björkström, Sven d Sjöstedt, Åke e Folestad, Agnetha a Arfwidsson, Ann Christin b Elvander, Christine Sareyko b Frison, Lars b

a SAHLGRENSKA UNIVERSITY HOSPITAL (Sweden)

b ASTRAZENECA R AND D (Sweden)

c NU Hospital Organisation (Sweden)

d Varbergs Hospital (Sweden)

e Section of Haematology (Sweden)

Author keywords

Deep vein thrombosis; Direct thrombin inhibitor; Melagatran; Orthopaedics; Venous thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; CYCLODEXTRIN; DEXTRAN; MELAGATRAN; METFORMIN; NONSTEROID ANTIINFLAMMATORY AGENT; POLOXAMER; SODIUM CHLORIDE; AZETIDINE DERIVATIVE; BENZYLAMINE DERIVATIVE; DRUG DERIVATIVE; FIBRINOLYTIC AGENT; GLYCINE;

ADULT; AGED; ANEMIA; BLEEDING; CLINICAL TRIAL; CONFERENCE PAPER; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; LUNG EMBOLISM; LUNG SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHLEBOGRAPHY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; THROMBOEMBOLISM; THROMBOSIS PREVENTION; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; VENOUS CIRCULATION; WOUND INFECTION; ADOLESCENT; ARTICLE; CHEMICALLY INDUCED DISORDER; HIP ARTHROPLASTY; KNEE ARTHROPLASTY; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; SUBCUTANEOUS DRUG ADMINISTRATION; VEIN THROMBOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; AZETIDINES; BENZYLAMINES; CYCLODEXTRINS; FEMALE; FIBRINOLYTIC AGENTS; GLYCINE; HEMORRHAGE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PHLEBOGRAPHY; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 0036507626 PISSN: 00493848 EISSN: None Source Type: Journal
DOI: 10.1016/S0049-3848(02)00038-5 Document Type: Conference Paper

Times cited : (22)

References (20)

1
- 0031729410
- Prevention of venous thromboembolism
- (1998) Chest , vol.114
- Clagett, G.P.¹ Anderson F.A., Jr.² Geerts, W.³ Heit, J.A.⁴ Knudson, M.⁵ Lieberman, J.R.⁶ Merli, G.J.⁷ Wheeler, H.B.⁸

2
- 0029915374
- Prevention of deep-vein thrombosis after total hip replacement: Direct thrombin inhibition with recombinant hirudin, CGP 39393
- (1996) Lancet , vol.347 , pp. 635-639
- Eriksson, B.I.¹ Ekman, S.² Kälebo, P.³ Zachrisson, B.⁴ Bach, D.⁵ Close, P.⁶

3
- 0030722727
- A comparison of recombinant hirudin with low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement
- (1997) N Engl J Med , vol.337 , pp. 1329-1335
- Eriksson, B.I.¹ Wille-Jorgensen, P.² Kalebo, P.³ Mouret, P.⁴ Rosencher, N.⁵ Bosch, P.⁶ Baur, M.⁷ Ekman, S.⁸ Bach, D.⁹ Lindbratt, S.¹⁰ Close, P.¹¹

4
- 0031729333
- New antithrombotic agents
- (1999) Chest , vol.114
- Weitz, J.I.¹ Hirsch, J.²

5
- 0031984477
- Effects of melagatran, a new low-molecular-weight thrombin inhibitor, on thrombin and fibrinolytic enzymes
- (1998) Thromb Haemostasis , vol.79 , pp. 110-118
- Gustafsson, D.¹ Antonsson, T.² Bylund, R.³ Eriksson, U.⁴ Gyzander, E.⁵ Nilsson, I.⁶ Elg, M.⁷ Mattsson, C.⁸ Deinum, J.⁹ Pehrsson, S.¹⁰ Karlsson, O.¹¹ Nilsson, A.¹² Sorensen, H.¹³

6
- 0030771611
- Antithrombotic effect of two low molecular weight thrombin inhibitors and a low-molecular weight heparin in a caval vein thrombosis model in the rat
- (1997) Thromb Haemostasis , vol.78 , pp. 1404-1407
- Eriksson, B.I.¹ Carlsson, S.² Halvarsson, M.³ Risberg, B.⁴ Mattsson, C.⁵

7
- 0000032946
- The antithrombotic effects of the oral, direct thrombin inhibitor H 376/95 and other anticoagulants tested in a deep venous thrombus treatment conscious rat model
- (2000) Haemostasis , vol.30 SI , pp. 166
- Carlsson, S.¹ Adler, G.² Elg, M.³

8
- 0033135457
- Antithrombotic effects and bleeding time of thrombin inhibitors and warfarin in the rat
- (1999) Thromb Res , vol.94 , pp. 187-197
- Elg, M.¹ Gustafsson, D.² Carlsson, S.³

9
- 0002439866
- Single and repeated oral dosing of H 376/95, a prodrug of the direct thrombin inhibitor melagatran, to young healthy male subjects
- (1999) Blood , vol.94 SI
- Eriksson, U.G.¹ Johansson, L.² Frison, L.³ Bredberg, U.⁴ Gustafsson, D.⁵

10
- 0003288144
- Effects of melagatran, a novel direct thrombin inhibitor, in healthy volunteers following intravenous, subcutaneous and oral administration
- (1999) Blood , vol.94 SI
- Bredberg, U.¹ Eriksson, U.G.² Taure, K.³ Johansson, L.⁴ Frison, L.⁵ Gustafsson, D.⁶

11
- 0036165984
- Determination of melagatran, a novel direct thrombin inhibitor, in human plasma and urine by liquid chromatography-mass spectrometry
- (2001) J Chromatogr B , vol.766 , pp. 47-55
- Larsson, M.¹ Logren, U.² Ahnoff, M.³ Lindmark, B.⁴ Abrahamsson, P.⁵ Svennberg, H.⁶ Persson, B.-A.⁷

12
- 0015289694
- Roentgen diagnosis of venous thrombosis in the leg
- (1972) Arch Surg , vol.104 , pp. 134-144
- Rabinov, K.¹ Paulin, S.²

13
- 0030457208
- Percentage of inadequate phlebograms and observer agreement in thromboprophylactic multicenter trials using standardized methodology and central assessment
- (1996) Thromb Haemostasis , vol.76 , pp. 893-896
- Kälebo, P.¹ Ekman, S.² Lindbratt, S.³ Eriksson, B.I.⁴ Pauli, U.⁵ Zachrisson, B.E.⁶ Close, P.⁷

14
- 0031090809
- Optimization of ascending phlebography of the leg for screening of deep vein thrombosis in thromboprophylactic trials
- (1997) Acta Radiol , vol.38 , pp. 320-326
- Kälebo, P.¹ Anthmyr, B.A.² Eriksson, B.I.³ Zachrisson, B.E.⁴

15
- 0018631477
- Ventilation-perfusion studies in suspected pulmonary embolism
- (1979) AJR, Am J Roentgenol , vol.133 , pp. 1033-1037
- Biello, D.R.¹ Mattar, A.G.² McKnight, R.C.³ Siegel, B.A.⁴

16
- 0027504813
- A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation
- (1993) N Engl J Med , vol.329 , pp. 1370-1376
- Hull, R.¹ Raskob, G.² Pineo, G.³ Rosenbloom, D.⁴ Evans, W.⁵ Mallory, T.⁶ Anquist, K.⁷ Smith, F.⁸ Hughes, G.⁹ Green, D.¹⁰ Elliot, C.G.¹¹ Panju, A.¹² Brant, A.¹³

17
- 0033008172
- Pharmacokinetics and pharmacodynamics of melagatran, a novel synthetic LMW thrombin inhibitor, in patients with acute DVT
- (1999) Thromb Haemostasis , vol.81 , pp. 358-363
- Eriksson, H.¹ Eriksson, U.G.² Frison, L.³ Hansson, P.O.⁴ Held, P.⁵ Holmström, M.⁶ Hägg, A.⁷ Jonsson, T.⁸ Lapidus, L.⁹ Leijd, B.¹⁰ Stockelberg, D.¹¹ Säfwenberg, U.¹² Taghavi, A.¹³ Thorsén, M.¹⁴

18
- 0025851944
- Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin
- (1991) J Bone Jt Surg, Am , vol.73 , pp. 484-493
- Eriksson, B.I.¹ Kalebo, P.² Anthymyr, B.A.³ Wadenvik, H.⁴ Tengborn, L.⁵ Risberg, B.⁶

19
- 0027985641
- Use of Hirulog in the prevention of venous thrombosis after major hip or knee surgery
- (1994) Circulation , vol.90 , pp. 2385-2389
- Ginsberg, J.S.¹ Nurmohamed, M.T.² Gent, M.³ MacKinnon, B.⁴ Sicurella, J.⁵ Brill-Edwards, P.⁶ Levine, M.N.⁷ Panju, A.A.⁸ Powers, P.⁹ Stevens, P.¹⁰ Turpie, A.G.G.¹¹ Weitz, J.¹² Buller, H.R.¹³ Ten Cate, J.W.¹⁴ Neemeh, J.¹⁵ Adelman, B.¹⁶ Fox, I.¹⁷ Maraganore, J.¹⁸ Hirsh, J.¹⁹

20
- 0036171348
- A dose-ranging study of the oral direct thrombin inhibitor, ximelagatran, and its subcutaneous form, melagatran, compared with dalteparin in the prophylaxis of thromboembolism after hip or knee replacement: METHRO I
- (2002) Thromb Haemostasis , vol.87 , pp. 231-237
- Eriksson, B.I.¹ Arfwidsson, A.-C.² Frison, L.³ Eriksson, U.G.⁴ Bylock, A.⁵ Kälebo, P.⁶ Fager, G.⁷ Gustafsson, D.⁸

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.